Plant Innovation Center, Japan Tobacco, Inc., 700 Higashibara, Iwata, Shizuoka 438-0802, Japan.
J Biotechnol. 2010 Feb 15;145(4):317-22. doi: 10.1016/j.jbiotec.2009.12.012. Epub 2009 Dec 22.
Tamavidin 2 is a fungal avidin-like protein that binds biotin with high affinity and is highly produced in soluble form in Escherichia coli. By contrast, widely used biotin-binding proteins avidin and streptavidin are rarely produced in soluble form in E. coli. In this study, we describe an efficient system for one-step purification and immobilization of recombinant proteins using tamavidin 2 as an affinity tag. A bacterial sialyltransferase and soybean agglutinin were fused to tamavidin 2 and expressed in E. coli and tobacco BY-2 cells, respectively. High-level expressions of the fusion proteins were detected (80 mg l(-1)E. coli culture for bacterial sialyltransferase-tamavidin 2 and 2 mg l(-1) BY-2 cell culture for soybean agglutinin-tamavidin 2). To immobilize and purify the fusion proteins, biotinylated magnetic microbeads were incubated with the soluble extract from each recombinant host producing the fusion protein and then washed thoroughly. As the result, both fusion proteins were immobilized tightly on the microbeads without substantial loss of activity and simultaneously highly purified (90-95% purity) on the microbeads. Biotin with a longer linker contributed to higher affinity between the fusion protein and biotin. These results suggest that tamavidin fusion technology is a powerful tool for production, purification, and immobilization of recombinant proteins.
Tamavidin 2 是一种真菌亲和素样蛋白,能够高亲和力结合生物素,并且在大肠杆菌中以可溶形式高度表达。相比之下,广泛使用的生物素结合蛋白亲和素和链霉亲和素很少以可溶形式在大肠杆菌中表达。在这项研究中,我们描述了一种使用 tamavidin 2 作为亲和标签一步纯化和固定化重组蛋白的有效系统。细菌唾液酸转移酶和大豆凝集素分别与 tamavidin 2 融合,并在大肠杆菌和烟草 BY-2 细胞中表达。融合蛋白的高水平表达得到了检测(大肠杆菌培养物中细菌唾液酸转移酶-tamavidin 2 的表达量为 80 mg l(-1),BY-2 细胞培养物中大豆凝集素-tamavidin 2 的表达量为 2 mg l(-1))。为了固定和纯化融合蛋白,将生物素化的磁性微球与每个产生融合蛋白的重组宿主的可溶性提取物孵育,然后彻底洗涤。结果,两种融合蛋白都紧密固定在微球上,没有明显的失活,并且在微球上高度纯化(纯度为 90-95%)。带有更长连接物的生物素有助于融合蛋白与生物素之间更高的亲和力。这些结果表明,tamavidin 融合技术是生产、纯化和固定化重组蛋白的有力工具。